(+)-Taxifolin

CAS No. 17654-26-1

(+)-Taxifolin( —— )

Catalog No. M19355 CAS No. 17654-26-1

Flavonoid, antioxidant. Inhibits lipogenesis in cancer cells, most likely by targeting fatty acid synthase activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 245 In Stock
10MG 412 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (+)-Taxifolin
  • Note
    Research use only, not for human use.
  • Brief Description
    Flavonoid, antioxidant. Inhibits lipogenesis in cancer cells, most likely by targeting fatty acid synthase activity.
  • Description
    Flavonoid, antioxidant. Inhibits lipogenesis in cancer cells, most likely by targeting fatty acid synthase activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    42-residue amyloid β-protein|cytochrome b5
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    17654-26-1
  • Formula Weight
    304.25
  • Molecular Formula
    C15H12O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CC(=C(C=C1[C@@H]2[C@H](C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Peonidin-3-O-[6-O-(E...

    Peonidin-3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-P-Hydroxybenzoyl-β-D-glucoside}-β-D-glucoside]-5-O-β-D-glucoside

  • Adrenomedullin (1-50...

    Adrenomedullin (1-50), rat is a 50 amino acid peptide, which induces a selective arterial vasodilation via activation of CGRP1 receptor. Adrenomedullin (1-50) is a peptide hormone with RNA expressed in rat adrenal glands, lung, kidney, heart, and spleen, as well as in the duodenum and submandibular glands.

  • EN6

    EN6-mediated ATP6V1A modification decouples the v-ATPase from the Rags, leading to inhibition of mTORC1 signaling.